Article 83: Formal Non-Compliance
Article 83 addresses purely formal (administrative) non-compliance — situations where the AI system itself may be technically sound but the provider has failed to meet procedural and documentation requirements. A Member State shall require the provider to end the non-compliance where it finds any of six specific deficiencies: (a) CE marking affixed in violation of Article 48; (b) CE marking not affixed; (c) EU declaration of conformity not drawn up; (d) EU declaration of conformity not drawn up correctly; (e) registration in the EU database not carried out; (f) authorised representative not designated where required. If the formal non-compliance persists, the Member State may restrict, prohibit, withdraw, or recall the system. This provision separates paperwork failures from substantive risk — the system may work perfectly, but without the formal compliance infrastructure it cannot legally remain on the market. Always verify on EUR-Lex.
Who does this apply to?
- -Providers who have neglected formal compliance steps — CE marking, declaration of conformity, EU database registration, or authorised representative designation
- -Market surveillance authorities conducting documentation and administrative compliance checks
- -Importers and distributors who must verify formal compliance requirements before making a system available on the market
Scenarios
A non-EU AI provider places a high-risk recruitment AI system on the EU market through a European distributor. The system has undergone conformity assessment, but the provider failed to designate an authorised representative in the Union as required by Article 22. The distributor did not verify this before making the system available.
A European MedTech company develops a high-risk AI system for patient triage. The system passes its conformity assessment, but due to an administrative oversight, the EU declaration of conformity is drawn up incorrectly — it references the wrong conformity assessment procedure and omits the notified body's identification number.
What Article 83 does (plain language)
Article 83 tackles the administrative side of AI Act compliance. The AI system itself may be perfectly safe and technically conformant, but if the paperwork is missing or wrong, the provider is formally non-compliant. The six specific triggers are:
- (a) CE marking affixed in violation of Article 48 (e.g., applied before conformity assessment is complete, or applied to a system that doesn't qualify)
- (b) CE marking not affixed at all when required
- (c) EU declaration of conformity not drawn up
- (d) EU declaration of conformity drawn up incorrectly (wrong references, missing information, incorrect format)
- (e) Registration in the EU database (Article 49) not carried out
- (f) Authorised representative not designated where required under Article 22
These are binary checks — the authority does not need to evaluate risk or conduct a technical assessment. Either the paperwork exists and is correct, or it doesn't.
Enforcement escalation for formal non-compliance
Article 83 follows a two-stage approach:
Stage 1 — Correction request: The Member State requires the provider to end the non-compliance within a specified period. This is straightforward — affix the CE marking, draw up or correct the declaration, complete the EU database registration, or designate an authorised representative.
Stage 2 — Market restriction: If the formal non-compliance persists beyond the correction period, the Member State shall take all appropriate measures to restrict or prohibit the AI system from being made available on the market, or ensure it is withdrawn or recalled.
The key distinction from Articles 79–82 is that the system does not need to present a risk — the mere absence of formal compliance is sufficient to trigger enforcement.
How Article 83 connects to the rest of the Act
- Article 47 — EU declaration of conformity: the document that must be drawn up correctly.
- Article 48 — CE marking rules: the marking that must be properly affixed.
- Article 49 — EU database registration: the registration that must be completed.
- Article 22 — Authorised representative designation for non-EU providers.
- Article 79 — Substantive risk procedure (contrasts with Article 83's formal approach).
- Article 99 — Penalties for non-compliance.
- Article 113 — Application dates; Article 83 applies from 2 August 2026.
Official wording (excerpt): Article 83
Editorial note: The full authentic text of Article 83 is published on EUR-Lex. The following is a faithful summary of its core operative provisions.
Where a Member State finds one of the following, it shall require the relevant provider to put an end to the non-compliance concerned: (a) the CE marking has been affixed in violation of Article 48; (b) the CE marking has not been affixed; (c) the EU declaration of conformity referred to in Article 47 has not been drawn up; (d) the EU declaration of conformity referred to in Article 47 has not been drawn up correctly; (e) the registration in the EU database referred to in Article 49 has not been carried out; (f) where applicable, no authorised representative has been appointed. Where the non-compliance referred to in the first subparagraph persists, the Member State concerned shall take all appropriate measures to restrict or prohibit the high-risk AI system from being made available on the market or ensure that it is recalled or withdrawn from the market.
Compliance checklist
- Verify CE marking is affixed in strict compliance with Article 48 — correct format, placement, and only after conformity assessment is complete.
- Draw up the EU declaration of conformity under Article 47 with all required elements: identification of the AI system, provider details, conformity assessment procedure used, notified body reference (if applicable), and signature.
- Complete EU database registration under Article 49 before placing the system on the market — verify the registration is accessible and accurate.
- Non-EU providers: designate an authorised representative in the Union under Article 22 with a written mandate covering all relevant obligations.
- Importers: verify all formal compliance elements (CE marking, declaration, registration, authorised representative) before making the system available on the EU market.
- Distributors: conduct reasonable checks that the system bears CE marking and is accompanied by the required documentation before further distribution.
- Create an internal compliance checklist that mirrors Article 83's six triggers — run it before every market placement.
Audit your formal compliance—start the free assessment.
Start Free AssessmentRelated Articles
Article 47: EU Declaration of Conformity
Article 48: CE Marking for High-Risk AI Systems
Article 49: EU Database Registration
Article 22: Authorised Representatives of Providers of High-Risk AI Systems
Article 79: Procedure at National Level for AI Systems Presenting a Risk
Article 99: Penalties for AI Act Infringements
Article 113: Entry into Force and Application Dates
Related annexes
- annex-v
Frequently asked questions
Can my system be removed from the market just for missing paperwork?
Yes. Article 83 explicitly allows market restriction, prohibition, withdrawal, or recall for persistent formal non-compliance — even if the system itself is technically sound and presents no risk. The formal requirements (CE marking, declaration of conformity, EU database registration, authorised representative) are legal preconditions for market access.
What is the difference between Article 83 and Article 79?
Article 79 addresses systems that present a substantive risk (health, safety, fundamental rights, environment). Article 83 addresses purely administrative deficiencies — missing or incorrect documentation — regardless of whether the system presents any risk. A system can trigger both articles simultaneously if it has formal gaps and also presents a risk.
How quickly do I need to fix formal non-compliance?
The Member State sets a correction period. For straightforward fixes (e.g., correcting a declaration or completing a database registration), authorities typically expect rapid compliance. If the deficiency persists beyond the prescribed period, enforcement escalates to market restriction.